Contrasting effects of nitric oxide on food intake and GH secretion stimulated by a GH-releasing peptide

European Journal of Endocrinology

Volumn 144, Issue 2, 2001, Pages 155-162

  Rigamonti, A E ^a   Cella, S G ^a   Cavallera, G M ^a   Deghenghi, R ^a   Locatelli, V ^a   Pitsikas, N ^a   Muller E E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HEXARELIN; MOLSIDOMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APPETITE; ARTICLE; CANNULA; CONTROLLED STUDY; FEEDING BEHAVIOR; FOOD INTAKE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; STIMULATION;

EID: 0035111324     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1440155     Document Type: Article

References (57)

1. Endogenous nitric oxide: Physiology, pathology and clinical relevance
2. Nitric oxide gas: Mediator, modulator, and pathophysiologic entity
3. Nitric oxide synthase in the rat anterior pituitary gland and the role of nitric oxide in regulation of luteinizing hormone secretion
4. Inhibitory control of nitric oxide on the arginine-vasopressin and oxytocin response to hypoglycaemia in normal men
5. Role in nitric oxide in control of prolactin release by the adenohypophysis
6. Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase
7. Involvement of endogenous nitric oxide in the control of pituitary responsiveness to different elicitors of growth hormone release in prepubertal rats
8. Influence of nitric oxide on hypoglycemia- or angiotensin II-stimulated ACTH and GH secretion in normal men
9. Leptin and neuropeptide Y (NPY) modulate nitric oxide synthase: Further evidence for a role of nitric oxide in feeding
10. Competitive antagonism of nitric oxide synthase causes weight loss in mice
11. Effect of competitive antagonism of NO synthase on weight and food intake in obese and diabetic mice
12. Evidence that nitric oxide modulates food intake in mice
13. Measurement of nitric oxide synthase and its mRNA in genetically obese (ob/ob) mice
14. Inhibition of feeding by a nitric oxide synthase inhibitor: Effects of aging
15. Nitric oxide biochemistry
16. Targeting nitric oxide to its targets
17. Evidence that brain nitric oxide synthase is the major nitric oxide synthase isoform in the hypothalamus of the adult female rat and that nitric oxide potently regulates hypothalamic cGMP levels
18. Involvement of nitric oxide in growth hormone (GH)-releasing hormone-induced GH secretion in rat pituitary cells
19. Growth hormone secretagogues: The clinical future
20. Small peptides as potent releasers of growth hormone
21. Growth hormone response in man to L-692 429, a novel nonpeptide mimic of growth hormone-releasing peptide-6
22. Growth hormone-releasing peptides
23. A receptor in pituitary and hypothalamus that functions in growth hormone release
24. Effects of acute and repeated intravenous administration of L-692 585, a novel non-peptidyl growth hormone secretagogue, on plasma hormone, IGF-I, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles
25. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland
26. Neuroendocrine control of growth hormone secretion
27. Growth hormone secretagogues: Focus on the growth hormone-releasing peptides
28. Hexarelin, a potent GHRp analogue: Interactions with GHRH and clonideine in young and aged dogs
29. Mechanism of action of Hexarelin I. Growth hormone-releasing activity in the rat
30. The nitric oxide (NO) modulation of the GH-releasing activity of Hexarelin in young and old dogs
31. Anorectic activity of NG-nitro-L-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats
32. Food deprivation increases brain nitric oxide synthase and depress brain serotonin levels in rats
33. Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse
34. Intracerebroventricular growth hormone-releasing peptide-6 stimulates eating without affecting plasma growth hormone responses in rats
35. Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats
36. Novel hexarelin analogs stimualte feeding in the rat though a mechanism not involving growth hormone release
37. Six-week treatment with Hexarelin in young dogs: Evaluation of the GH responsiveness to acute Hexarelin or GHRH administration, and of the orexigenic effect of Hexarelin
38. In vitro, nitric oxide (NO) stimulates LH secretion and partially prevents the inhibitory effect of dopamine on PRL release
39. Blockade of nitric oxide formation impairs adrenergic-induced ACTH and corticosterone secretion
40. The role of nitric oxide in the control of basal and LHRH-stimulated LH secretion
41. The role of nitric oxide in L-arginine-stimulated growth hormone release
42. Comparison among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine, two nitric oxide donors, on hormonal secretion and blood pressure in man
43. L-arginine is unlikely to exert neuroendocrine effects in humans via the generation of nitric oxide
44. Brain-blood barrier? Yes and no
45. Effects of nitric oxide on neuroendocrine function and behavior
46. The nitric oxide hypothesis of brain aging
47. Endogenous nitric oxide inhibits growth hormone secretion through cyclic guanosine monophosphate-dependent mechanisms in GH3 cells
48. Nitric oxide stimulates growth hormone secretion in vitro through a calcium- and cyclic guanosine monophosphate-independent mechanism
49. Methylene blue inhibits stimulatory effect of sodium nitroprusside but not of 3-morpholino sydnonimine on prolactin secretion in freely moving male rats
50. The effects of xylazine on plasma concentrations insulin in calves
51. Clonidine or xylazine as provocative tests for growth hormone secretion in the dog
52. Inhibition of hypothalamic nitric oxide synthase gene expression in the rat paraventricular nucleus by food deprivation is independent of serotonin depletion
53. Growth hormone releasing substances: Types and their receptors
54. Distribution and metabolism on N(G)-nitro-L-arginine methyl ester in patients with septic shock
55. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): Requirement for bioactivation to the free acid. NG-nitro-L-arginine
56. Changes in follicle-stimulating hormone secretion in spontaneously hypertensive rats
57. Hypertension in young, healthy Zucker obese rats is not responsive to reduced salt intake